CT
SBIO icon

Cambridge Trust’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Cambridge Trust’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-516
Closed -$14K – 755
2023
Q1 		$14K Sell
516
-50
-9% -$1.51K ﹤0.01% 591
2022
Q4 		$17K Hold
566
– – ﹤0.01% 580
2022
Q3 		$17K Sell
566
-209
-27% -$6.6K ﹤0.01% 586
2022
Q2 		$21K Hold
775
– – ﹤0.01% 599
2022
Q1 		$26K Sell
775
-2,503
-76% -$86.7K ﹤0.01% 633
2021
Q4 		$138K Buy
+3,278
New +$146K ﹤0.01% 387
2021
Q3 		– Sell
-5,120
Closed -$250K – 281
2021
Q2 		$250K Sell
5,120
-6,171
-55% -$296K 0.01% 243
2021
Q1 		$568K Sell
11,291
-5,840
-34% -$323K 0.02% 166
2020
Q4 		$878K Sell
17,131
-4,245
-20% -$202K 0.04% 124
2020
Q3 		$879K Sell
21,376
-8,184
-28% -$338K 0.05% 122
2020
Q2 		$1.22M Sell
29,560
-1,356
-4% -$53.5K 0.06% 108
2020
Q1 		$980K Sell
30,916
-6,055
-16% -$232K 0.07% 116
2019
Q4 		$1.56M Sell
36,971
-1,686
-4% -$62.5K 0.08% 111
2019
Q3 		$1.22M Buy
38,657
+20,976
+119% +$737K 0.07% 121
2019
Q2 		$639K Sell
17,681
-430
-2% -$14.8K 0.04% 157
2019
Q1 		$655K Sell
18,111
-908
-5% -$30.3K 0.04% 152
2018
Q4 		$535K Sell
19,019
-752
-4% -$24.9K 0.04% 160
2018
Q3 		$778K Sell
19,771
-781
-4% -$29.6K 0.04% 145
2018
Q2 		$766K Sell
20,552
-1,562
-7% -$56.7K 0.05% 151
2018
Q1 		$757K Buy
22,114
+1,087
+5% +$38.1K 0.05% 152
2017
Q4 		$689K Buy
21,027
+119
+0.6% +$3.72K 0.04% 154
2017
Q3 		$652K Buy
20,908
+1,238
+6% +$36.3K 0.04% 155
2017
Q2 		$548K Buy
19,670
+3,304
+20% +$85.9K 0.04% 163
2017
Q1 		$422K Buy
+16,366
New +$407K 0.03% 199

Other funds holding SBIO

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cambridge Trust's SBIO Position: Q2 2023 in Review

Cambridge Trust sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2023, closing a stake of 516 shares — an estimated $14K sold.

Cambridge Trust first reported a position in SBIO in Q1 2017 and held it in 24 quarters. The position peaked at $1.56M in Q4 2019. 41 funds tracked by Wall St. Rank hold SBIO as of Q2 2023.

  • Cambridge Trust reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2023 after selling out during the quarter.
  • Cambridge Trust sold 516 ALPS Medical Breakthroughs ETF shares in Q2 2023, an estimated $14K.
  • Cambridge Trust first reported a position in ALPS Medical Breakthroughs ETF in Q1 2017 and held it in 24 quarters.
  • Cambridge Trust's ALPS Medical Breakthroughs ETF position peaked at $1.56M in Q4 2019.
  • 41 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2023.

Based on Cambridge Trust's 13F filing for Q2 2023, filed 25 Jul 2023.